Share

July 17, 2012; 79 (3) Articles

Lower serum vitamin D levels are associated with a higher relapse risk in multiple sclerosis

Tessel F. Runia, Wim C.J. Hop, Yolanda B. de Rijke, Dragan Buljevac, Rogier Q. Hintzen
First published June 13, 2012, DOI: https://doi.org/10.1212/WNL.0b013e31825fdec7
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
551

Share

Article Information

vol. 79 no. 3 261-266
DOI: 
https://doi.org/10.1212/WNL.0b013e31825fdec7
PubMed: 
22700811
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • Received June 18, 2011
  • Accepted November 14, 2011
  • First Published June 13, 2012.

Article Versions

Copyright & Usage: 
Copyright © 2012 by AAN Enterprises, Inc.

Author Disclosures

    1. Tessel F. Runia, MD,
    2. Wim C.J. Hop, PhD,
    3. Yolanda B. de Rijke, PhD,
    4. Dragan Buljevac, MD and
    5. Rogier Q. Hintzen, MD, PhD
  1. Tessel F. Runia, MD,
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers’ Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Wim C.J. Hop, PhD,
    3. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers’ Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. Yolanda B. de Rijke, PhD,
    4. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers’ Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  4. Dragan Buljevac, MD and
    5. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers’ Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  5. Rogier Q. Hintzen, MD, PhD
    6. Scientific Advisory Boards:

    1. Dutch MS research Foundation

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. msard

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers’ Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. From the Department of Neurology, MS Centre ErasMS (T.F.R., D.B., R.Q.H.), Department of Biostatistics (W.C.J.H.), and Departments of Clinical Chemistry and Internal Medicine (Y.B.d.R.), Erasmus MC, Rotterdam, the Netherlands.
  1. Correspondence & reprint requests to Prof. Hintzen: r.hintzen{at}erasmusmc.nl
View Full Text

Article usage

Article usage: June 2012 to May 2022

AbstractFullPdfSource
Jun 2012464057Highwire
Jul 201213092474Highwire
Aug 20128603380Highwire
Sep 2012453918Highwire
Oct 20125311730Highwire
Nov 20123551321Highwire
Dec 20121701410Highwire
Jan 201311999Highwire
Feb 20138032Highwire
Mar 20138519Highwire
Apr 201312125Highwire
May 20137821Highwire
Jun 20138649Highwire
Jul 20136336Highwire
Aug 20133712Highwire
Sep 20137415Highwire
Oct 201311136Highwire
Nov 20138035Highwire
Dec 20135454Highwire
Jan 20145443Highwire
Feb 20146513Highwire
Mar 20146567Highwire
Apr 20146670Highwire
May 20146595Highwire
Jun 20145033Highwire
Jul 20145956Highwire
Aug 201435324Highwire
Sep 20149553Highwire
Oct 20149637Highwire
Nov 20148757Highwire
Dec 20145344Highwire
Jan 20159797Highwire
Feb 20156124Highwire
Mar 20157034Highwire
Apr 20155221Highwire
May 20157387Highwire
Jun 20155336Highwire
Jul 20155954Highwire
Aug 20155202Highwire
Sep 20155625Highwire
Oct 20154646Highwire
Nov 20156352Highwire
Dec 20159510Highwire
Jan 201616425Highwire
Feb 20166932Highwire
Mar 20168343Highwire
Apr 20166832Highwire
May 20165821Highwire
Jun 20167903Highwire
Jul 20164921Highwire
Aug 20165210Highwire
Sep 20168531Highwire
Oct 201611100Highwire
Nov 201611800Highwire
Dec 20169811Highwire
Jan 20179854Highwire
Feb 20178004Highwire
Mar 201710733Highwire
Apr 20178400Highwire
May 20179000Highwire
Jun 20176221Highwire
Jul 20177312Highwire
Aug 20176921Highwire
Sep 20176700Highwire
Oct 20179642Highwire
Nov 20176702Highwire
Dec 201711010Highwire
Jan 20187821Highwire
Feb 20189242Highwire
Mar 20187220Highwire
Apr 20186100Highwire
May 20186412Highwire
Jun 20185110Highwire
Jul 20186200Highwire
Aug 20183502Highwire
Sep 20187232Highwire
Oct 20187933Highwire
Nov 20186100Highwire
Dec 20187900Highwire
Jan 20196200Highwire
Feb 20197112Highwire
Mar 20196033Highwire
Apr 20196202Highwire
May 20195231Highwire
Jun 20193810Highwire
Jul 20193503Highwire
Aug 20195601Highwire
Sep 20194962Highwire
Oct 20196710Highwire
Nov 20197301Highwire
Dec 20197154Highwire
Jan 20204423Highwire
Feb 20207211Highwire
Mar 20203311Highwire
Apr 20206721Highwire
May 20204601Highwire
Jun 20203540Highwire
Jul 20204944Highwire
Aug 20201600Highwire
Sep 20206122Highwire
Oct 20205043Highwire
Nov 20204421Highwire
Dec 20206200Highwire
Jan 20214600Highwire
Feb 20213532Highwire
Mar 20215175Highwire
Apr 20216740Highwire
May 20215500Highwire
Jun 20213200Highwire
Jul 20214600Highwire
Aug 20216720Highwire
Sep 20213800Highwire
Oct 20215832Highwire
Nov 20216000Highwire
Dec 20212710Highwire
Jan 20224200Highwire
Feb 20226900Highwire
Mar 20225900Highwire
Apr 20227022Highwire
May 20223821Highwire

Cited By...

Disputes & Debates: Rapid online correspondence

Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

Topics Discussed

Alert Me